15250-m-cuypers

147 Regret and information satisfaction at one-year follow-up 7 REFERENCES 1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA: A Cancer Journal for Clinicians. 2015;65(2):87-108. 2. Torre LA, Siegel RL, Ward EM, Jemal A. Global Cancer Incidence and Mortality Rates and Trends—An Update. Cancer Epidemiology Biomarkers & Prevention. 2016;25(1):16-27. 3. Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent— update 2013. Eur Urol. 2014;65. 4. Mottet N, Bellmunt J, Briers E, Association EU. Guidelines on prostate cancer. Eur Urol. 2014;65(1):124-37. 5. Chen RC, Rumble RB, LoblawDA, Finelli A, Ehdaie B, CooperbergMR, et al. Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement. Journal of Clinical Oncology. 2016;34(18):2182-90. 6. Ferrer M, Guedea F, Suárez JF, de Paula B, Macías V, Mariño A, et al. Quality of life impact of treatments for localized prostate cancer: Cohort study with a 5year follow-up. Radiotherapy and Oncology. 2013;108(2):306-13. 7. Bellardita L, Valdagni R, van den Bergh R, Randsdorp H, Repetto C, Venderbos LDF, et al. How Does Active Surveillance for Prostate Cancer Affect Quality of Life? A Systematic Review. European Urology. 2015;67(4):637-45. 8. Resnick MJ, Koyama T, Fan K-H, Albertsen PC, Goodman M, Hamilton AS, et al. Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer. New England Journal of Medicine. 2013;368(5):436-45. 9. Scherr KA, Fagerlin A, Hofer T, Scherer LD, Holmes-Rovner M, Williamson LD, et al. Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions. Medical Decision Making. 2017;37(1):56-69. 10. Chen RC, Clark JA, Mitchell SP, Talcott JA. Treatment “mismatch” in early prostate cancer: An empirical measure of patient-physician communication. Journal of Clinical Oncology. 2004;22(14_suppl):4566-. 11. Sidana A, Hernandez DJ, Feng Z, Partin AW, Trock BJ, Saha S, et al. Treatment decision- making for localized prostate cancer: What younger men choose and why. The Prostate. 2012;72(1):58-64. 12. Hoffman RM, Lo M, Clark JA, Albertsen PC, Barry MJ, Goodman M, et al. Treatment Decision Regret Among Long-Term Survivors of Localized Prostate Cancer: Results From the Prostate Cancer Outcomes Study. J Clin Oncol. 2017;35(20):2306-14. 13. Christie DRH, Sharpley CF, Bitsika V. Why do patients regret their prostate cancer treatment? A systematic review of regret after treatment for localized prostate cancer. Psycho-Oncology. 2015;24(9):1002-11.